Literature DB >> 2170447

Immune modulation of metalloproteinase production in human macrophages. Selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-gamma.

S D Shapiro1, E J Campbell, D K Kobayashi, H G Welgus.   

Abstract

Interferon-gamma (IFN-gamma) is a lymphokine that activates mononuclear phagocytes. To test the hypothesis that IFN-gamma might have important effects upon the ability of human mononuclear phagocytes to degrade extracellular matrix, we have studied the action of this cytokine on the production of metalloproteinases and the counterregulatory tissue inhibitor of metalloproteinases (TIMP) by the human alveolar macrophage. We have found that IFN-gamma potently and selectively suppresses the lipopolysaccharide-induced production of two metalloproteinases--interstitial collagenase and stromelysin--by 50-90% at doses greater than or equal to 10 U/ml. The synthesis of TIMP and 92-kD type IV collagenase was also diminished by IFN-gamma, but these responses required 50- to 100-fold higher concentrations of the cytokine. All doses of IFN-gamma increased total and secreted protein synthesis slightly, indicating a highly specific effect on metalloenzyme biosynthesis. Inhibition of metalloproteinase expression occurred at a pretranslational level, as evidenced by parallel reductions in enzyme biosynthesis and collagenase-specific steady-state mRNA levels. Interestingly, the effect of IFN-gamma on metalloenzyme production was not readily reversible. Therefore, while IFN-gamma activates the macrophage and renders it tumoricidal, this enhanced function appears to be attained at the expense of the cell's capacity to degrade extracellular matrix.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170447      PMCID: PMC296850          DOI: 10.1172/JCI114826

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Interferon gamma drastically modifies the regulation of interleukin 1 genes by endotoxin in U937 cells.

Authors:  C Ucla; P Roux-Lombard; S Fey; J M Dayer; B Mach
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

2.  Stimulation of in vitro human skin collagenase expression by platelet-derived growth factor.

Authors:  E A Bauer; T W Cooper; J S Huang; J Altman; T F Deuel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

Review 3.  Regulation of the mammalian collagenases.

Authors:  E D Harris; H G Welgus; S M Krane
Journal:  Coll Relat Res       Date:  1984-12

4.  Regulation of murine macrophage Ia antigen expression by an immune interferon-like lymphokine: inhibitory effect of endotoxin.

Authors:  P S Steeg; H M Johnson; J J Oppenheim
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

5.  Recombinant interferons increase macrophage Fc receptor capacity.

Authors:  D Fertsch; S N Vogel
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

6.  Elastase of U-937 monocytelike cells. Comparisons with elastases derived from human monocytes and neutrophils and murine macrophagelike cells.

Authors:  R M Senior; E J Campbell; J A Landis; F R Cox; C Kuhn; H S Koren
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

7.  Enzyme-linked immunosorbent assay for human skin collagenase.

Authors:  T W Cooper; E A Bauer; A Z Eisen
Journal:  Coll Relat Res       Date:  1983-05

8.  Human skin fibroblast collagenase inhibitor. Purification and biochemical characterization.

Authors:  G P Stricklin; H G Welgus
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

9.  Human skin fibroblast collagenase inhibitor. Comparative studies in human connective tissues, serum, and amniotic fluid.

Authors:  H G Welgus; G P Stricklin
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

10.  Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity.

Authors:  A Celada; P W Gray; E Rinderknecht; R D Schreiber
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

View more
  33 in total

Review 1.  Matrix metalloproteinase biology applied to vitreoretinal disorders.

Authors:  C S Sethi; T A Bailey; P J Luthert; N H Chong
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

Review 2.  T lymphocyte and fibroblast interactions: the case of skin involvement in systemic sclerosis and other examples.

Authors:  C Chizzolini
Journal:  Springer Semin Immunopathol       Date:  1999

3.  Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas.

Authors:  Koichi Shimizu; Masayoshi Shichiri; Peter Libby; Richard T Lee; Richard N Mitchell
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 4.  Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted.

Authors:  Kendra J Greenlee; Zena Werb; Farrah Kheradmand
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

Review 5.  Macrophages in hepatitis B and hepatitis C virus infections.

Authors:  Mathis Heydtmann
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

6.  Lipopolysaccharide-induced expression of matrix metalloproteinases in human monocytes is suppressed by IFN-gamma via superinduction of ATF-3 and suppression of AP-1.

Authors:  Hao H Ho; Taras T Antoniv; Jong-Dae Ji; Lionel B Ivashkiv
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

7.  Predominance of type 1 CD4+ T cells in human abdominal aortic aneurysm.

Authors:  C Galle; L Schandené; P Stordeur; Y Peignois; J Ferreira; J-C Wautrecht; J-P Dereume; M Goldman
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

Review 8.  The matrix metalloproteinases and their inhibitors in pancreatic cancer. From molecular science to a clinical application.

Authors:  S R Bramhall
Journal:  Int J Pancreatol       Date:  1997-02

9.  IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes.

Authors:  S Lacraz; L P Nicod; R Chicheportiche; H G Welgus; J M Dayer
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

10.  Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase.

Authors:  P A Hill; A J Docherty; K M Bottomley; J P O'Connell; J R Morphy; J J Reynolds; M C Meikle
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.